- Home
- YYAI vs KZIA Comparison
YYAI vs KZIA Comparison
Compare YYAI & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YYAI
- KZIA
- Stock Information
- Founded
- YYAI 2015
- KZIA 1994
- Country
- YYAI United States
- KZIA Australia
- Employees
- YYAI N/A
- KZIA N/A
- Industry
- YYAI
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- YYAI
- KZIA Health Care
- Exchange
- YYAI NYSE
- KZIA Nasdaq
- Market Cap
- YYAI 19.5M
- KZIA 12.6M
- IPO Year
- YYAI N/A
- KZIA 1999
- Fundamental
- Price
- YYAI $6.10
- KZIA $0.37
- Analyst Decision
- YYAI
- KZIA Strong Buy
- Analyst Count
- YYAI 0
- KZIA 1
- Target Price
- YYAI N/A
- KZIA $2.00
- AVG Volume (30 Days)
- YYAI 70.2K
- KZIA 667.0K
- Earning Date
- YYAI 10-03-2024
- KZIA 09-17-2024
- Dividend Yield
- YYAI N/A
- KZIA N/A
- EPS Growth
- YYAI N/A
- KZIA N/A
- EPS
- YYAI N/A
- KZIA N/A
- Revenue
- YYAI $8,398,049.00
- KZIA $382.00
- Revenue This Year
- YYAI N/A
- KZIA $4,053,954.00
- Revenue Next Year
- YYAI N/A
- KZIA N/A
- P/E Ratio
- YYAI N/A
- KZIA N/A
- Revenue Growth
- YYAI N/A
- KZIA N/A
- 52 Week Low
- YYAI $2.90
- KZIA $0.19
- 52 Week High
- YYAI $214.40
- KZIA $1.58
- Technical
- Relative Strength Index (RSI)
- YYAI 32.05
- KZIA 47.89
- Support Level
- YYAI $5.66
- KZIA $0.36
- Resistance Level
- YYAI $6.47
- KZIA $0.45
- Average True Range (ATR)
- YYAI 1.00
- KZIA 0.04
- MACD
- YYAI -0.05
- KZIA 0.00
- Stochastic Oscillator
- YYAI 13.10
- KZIA 28.64
About YYAI CONNEXA SPORTS TECHNOLOGIES IN
Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.